Pruritus
Showing 9426 - 9450 of >10,000
Influenza Trial in Allschwil (Inflexal V)
Completed
- Influenza
- Inflexal V
-
Allschwil, SwitzerlandCovance Clinical Research Unit AG
Dec 19, 2013
Tumors Trial in Toulouse Cedex, Villejuif Cedex (BIBW 2992 low (20mg) dosage, BIBW 2992 medium (40mg) dosage, BIBW 2992 high
Completed
- Neoplasms
- BIBW 2992 low (20mg) dosage
- +5 more
-
Toulouse Cedex, France
- +1 more
Jun 3, 2014
Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Atlanta (G-CSF plus plerixafor, rituximab)
Completed
- Non-Hodgkin Lymphoma
- Hodgkin Disease
- G-CSF plus plerixafor
- rituximab
-
Atlanta, GeorgiaWinship Cancer Institute
Feb 10, 2014
Abscess, Wound Infection, Surgical Site Infection Trial in Worldwide (Dalbavancin, Vancomycin / Linezolid)
Completed
- Abscess
- +3 more
- Dalbavancin
- Vancomycin / Linezolid
-
Anaheim, California
- +91 more
Dec 26, 2013
Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer Trial in United States (PCI-27483, Gemcitabine)
Completed
- Pancreatic Cancer
- +2 more
-
Scottsdale, Arizona
- +16 more
Apr 4, 2014
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
-
Tucson, Arizona
- +42 more
Apr 7, 2014
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- clofarabine
- +2 more
-
Birmingham, Alabama
- +12 more
Mar 17, 2014
Arthroplasty, Replacement, Knee, Thromboembolism Trial in Worldwide (Dabigatran Dose 1 - day 2 to completion, Dabigatran Dose 1
Completed
- Arthroplasty, Replacement, Knee
- Thromboembolism
- Dabigatran Dose 1 - day 2 to completion
- +4 more
-
Birmingham, Alabama
- +93 more
Apr 22, 2014
Dry Eye Syndromes Trial in Japan (OPC-12759 Ophthalmic suspension, Hyalein Mini Ophthalmic solution)
Completed
- Dry Eye Syndromes
- OPC-12759 Ophthalmic suspension
- Hyalein Mini Ophthalmic solution
-
Kagoshima, Japan
- +4 more
Nov 18, 2013
Fracture Distal Radius Trial in Hatyai (Baby talcum)
Unknown status
- Fracture Distal Radius
- Baby talcum
-
Hatyai, Songkhla, ThailandPrince of Songkla university
May 12, 2012
Tinea Pedis Trial in Puerto Rico, United States (NAFT-600 ( naftin 2 % gel ), Placebo)
Completed
- Tinea Pedis
- NAFT-600 ( naftin 2 % gel )
- Placebo
-
Phoenix, Arizona
- +22 more
Jul 26, 2013
Polycystic Ovarian Syndrome Trial in Toulouse (Cetrorelix acetate, Recombinant Human Choriogonadotropin (r-hCG), Recombinant
Completed
- Polycystic Ovarian Syndrome
- Cetrorelix acetate
- +2 more
-
Toulouse, FranceResearch Site
Jan 20, 2014
Influenza, Orthomyxovirus Infection, Myxovirus Infection Trial in United States (Influenza Virus Vaccine USP Trivalent Types A
Completed
- Influenza
- +2 more
- Influenza Virus Vaccine USP Trivalent Types A and B
-
Hoover, Alabama
- +27 more
Dec 5, 2013
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in United States (irinotecan HCl, leucovorin
Terminated
- Recurrent Colon Cancer
- +5 more
- irinotecan hydrochloride
- +4 more
-
Ft. Smith, Arkansas
- +381 more
Jul 25, 2014
Malignant Glioma of Brain Trial in Durham (Irinotecan, Panitumumab)
Terminated
- Malignant Glioma of Brain
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University M
Jul 29, 2013
Advanced Cancer, Advanced Solid Tumors Trial in United States (CP-751,871, Sunitinib)
Terminated
- Advanced Cancer
- Advanced Solid Tumors
-
Los Angeles, California
- +3 more
May 21, 2014
Depressive Disorder, Major Trial in United States (Vortioxetine, Placebo)
Prostate Cancer Trial in United States (docetaxel, hydroxychloroquine)
Terminated
- Prostate Cancer
-
Hamilton, New Jersey
- +6 more
Sep 23, 2013
Indian Advanced Renal Cell Cancer Receiving Therapy With Sutent
Completed
- Renal Cell Carcinoma
- Non Interventional
-
New Delhi, Delhi, India
- +6 more
Nov 26, 2013
Chronic Plaque Psoriasis Trial in Vienna (Efalizumab - anti CD11a recombinant human mAb, Placebo)
Terminated
- Chronic Plaque Psoriasis
- Efalizumab - anti CD11a recombinant human monoclonal antibody
- Placebo
-
Vienna, AustriaUniversity of Vienna Medical School
Jan 26, 2014